08Feb 2025
Additional Rituximab Infusion Prevents Early Relapse in Pemphigus

Additional Rituximab Infusion Prevents Early Relapse in Pemphigus

Adding a rituximab infusion at 6 months significantly reduces early relapse in pemphigus patients. A cohort study of 87 patients showed relapse rates dropped from 17.6% to 2.6% in year 1. The study included 64 patients with pemphigus vulgaris and 23 with pemphigus foliaceus. Predictors such as PDAI score and anti-DSG1/DSG3 antibodies were key in identifying high-risk patients. The NNT to prevent relapse was 3.6.

  • #dermatology

Like

Save

Share